Skip to main content
. 2025 Sep 9;16:1664621. doi: 10.3389/fendo.2025.1664621

Table 1.

Clinical, hormonal and radiological characteristics of patients at diagnosis, overall and divided by gender.

Variables Total (n = 62) Males (n = 23) Females (n = 39) P-value
Age (years) 37.0 (26.5 – 45.3) 44.0 (32.0 - 50.0) 34.0 (22.0 - 42.0) 0.40
Radiology
 Microadenoma 30 (48.4%) 4 (17.4%) 26 (66.7%) < 0.0001
 Macroadenoma 32 (51.6%) 19 (82.6%) 13 (33.3%) < 0.0001
 Maximum diameter (mm) 9.5 (5.0 - 19.3) 20.0 (15.0 - 30.0) 7.0 (4.0 - 12.0) < 0.0001
 Volume (mm3) 1361 (109 - 3120) 2246 (1195 - 7047) 133 (39 - 1026) < 0.05
 Cavernous sinus invasion 11 (17.7%) 7 (30.4%) 4 (10.3%) < 0.05
 Surgery 7 (11.3%) 3 (13.0%) 4 (10.3%) 0.74
 Symptoms at diagnosis 46 (74.2%) 20 (87%) 26 (66,7%) 0.08
 Compressive symptoms 14 (22.6%) 9 (39.1%) 5 (12,8%) < 0.05
 Visual defect 13 (21.0%) 7 (30.4%) 6 (15,4%) 0.16
 Hormonal deficits 18 (29.0%) 14 (60.9%) 4 (10.3%) < 0.0001
Hormones levels
 PRL (ng/ml) 187.4 (80.1 - 779.6) 683.0 (178.0 - 1000) 145.5 (69.0 - 301.0) < 0.05
 TSH (mU/L) 1.6 (1.3 - 2.1) 1.5 (1.0 - 1.7) 1.9 (1.5 - 2.5) 0.14
 fT4 (ng/dL) 1.2 (0.9 - 1.2) 1.0 (0.8 - 1.2) 1.2 (1.1 - 1.3) < 0.05
 Cortisol (µg/dL) 12.4 (8.6 - 17.6) 12.6 (9.1 - 17.6) 9.4 (6.7 - 18.7) 0.61
 IGF-I (ng/mL) 152.6 (123.5 - 179.5) 152.6 (123.5 - 179.5) 146.6 (68.8 - 372.0) 1.00
 ACTH (pg/mL) 30.2 (16.1 - 38.6) 34.7 (17.9 - 42.6) 17.1 (11.9 - 33.7) 0.09
 FSH (mU/L) 2.9 (1.7 - 6.5) 2.1 (1.5 - 5.0) 5.0 (2.1 - 8.5) 0.13
 LH (mU/L) 2.1 (0.5 - 8.0) 1.7 (0.8 - 5.9) 2.7 (0.3 - 9.8) 0.89
 Dose of DA (mg/sett) 1.0 (0.5 - 1.4) 1.0 (1.2 - 3.1) 0.5 (0.5 - 1.0) 0.001

Data are expressed as median and interquartile range (IQR) or absolute number and percentage.

Comparisons between groups were performed with χ2 test for dichotomous or categorical variables, Student's t test for continuous normally distributed variables and Mann-Whitney test for continuous not normally distributed variables.

Significant differences are shown in bold characters.